Global Regenerative Drugs Market Size, Share, Opportunities, And Trends By Type (Synthetic, Biologically Derived, Genetically Derived), By Materials (Biodegradable Synthetic Polymers, Scaffold, Hydrogel & Collagen, Transgenic And Fibroblasts), By Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, Others), By End Users (Hospitals, Biomedical Laboratories And Research Centres), And By Geography - Forecasts From 2023 To 2028

  • Published : Mar 2021
  • Report Code : KSI061611188
  • Pages : 114

The global regenerative drugs market will witness robust growth over the forecast period.

Regenerative drugs or medicines are used to heal body tissues or organs from within. The process is called rejuvenation in which these medicines repair the damaged body organs which otherwise cannot heal naturally. Regenerative medicines also help in the replacement where healthy cells, tissues, or organs are used from a dead or healthy donor to replace damaged cells, tissues, or organs. The other way to heal damaged tissue with these medicines is by delivering healthy cells or tissues to diseased or damaged cells in order to retain the body’s normal functioning which is known as regeneration.

Regenerative drugs also increase the possibility of growing organs in lab conditions, where cells from the patient’s own body can be used for regeneration which can reduce the chances of organ transplant rejection. Companies like Baxter International, Stryker Corporation, Medtronic plc., Cryolife, Inc., and Organogenesis, Inc (Advanced Biohealing) are among the major key players in the global regenerative drugs market.

By Type

On the basis of types, the global regenerative drugs market is segmented as synthetic, biologically derived, and genetically derived.

By Materials

On the basis of materials, the global regenerative drugs market is segmented as biodegradable synthetic polymers, scaffolds, hydrogel & collagen, transgenic, and fibroblasts.

By Application

On the basis of application, the global regenerative drugs market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others.

By End-Users

End-users of the global regenerative drugs market include hospitals, biomedical laboratories, and research centers.

By Geography

Geographically, the global regenerative drugs market is segmented into North America, South America, Europe, the Middle East, and the Asia Pacific region. Germany, France, and the UK are the major hubs that have a significant European commercial sector for regenerative medicines. These include mostly cell-based therapies from the patient’s own body and also from unrelated donors.


  • By Technology
  • Stem cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Small Molecules & Biologics


  • By Materials
  • Biodegradable Synthetic Polymers
  • Scaffold
  • Hydrogel & Collagen
  • Transgenic
  • Fibroblasts


  • By Applications
  • Cardiovascular
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Ophthalmology
  • Neurology
  • Others


  • By End-Users
  • Hospitals
  • Biomedical Laboratories
  • Research Centers


  • By Geography
  • North America
  • South America
  • Europe
  • Middle East and Africa (MEA)
  • Asia Pacific (APAC)

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
5. Global Regenerative Drugs Market Forecast by Type (US$ Billion)
5.1. Introduction
5.2. Synthetic
5.3. Biologically Derived
5.4. Genetically Derived
6. Global Regenerative Drugs Market Forecast by Technology (US$ Billion)
6.1. Introduction
6.2. Stem cell Therapy
6.3. Gene Therapy
6.4. Tissue Engineering
6.5. Small Molecules & Biologics
7. Global Regenerative Drugs Market Forecast by Materials (US$ Billion)
7.1. Introduction
7.2. Biodegradable Synthetic Polymers
7.3. Scaffold
7.4. Hydrogel & Collagen
7.5. Transgenic
7.6. Fibroblasts
8. Global Regenerative Drugs Market Forecast by Applications (US$ Billion)
8.1. Introduction
8.2. Cardiovascular
8.3. Oncology
8.4. Dermatology
8.5. Musculoskeletal
8.6. Wound Healing
8.7. Ophthalmology
8.8. Neurology
8.9. Others
9. Global Regenerative Drugs Market Forecast by End-Users (US$ Billion)
9.1. Hospitals
9.2. Biomedical Laboratories
9.3. Research Centers
10. Global Regenerative Drugs Market Forecast by Geography (US$ Billion)
10.1. Introduction
10.2. North America
10.3. South America
10.4. Europe
10.5. Middle East and Africa (MEA)
10.6. Asia Pacific (APAC)
11. Competitive Intelligence
11.1. Market Share Analysis
11.2. Strategies of Key Players
11.3. Recent Investments and Deals
12. Company Profiles
12.1. Baxter International
12.1.1. Overview
12.1.2. Financials
12.1.3. Products and Services
12.1.4. Key Developments
12.2. Stryker Corporation
12.2.1. Overview
12.2.2. Financials
12.2.3. Products and Services
12.2.4. Key Developments
12.3. Medtronic plc.
12.3.1. Overview
12.3.2. Financials
12.3.3. Products and Services
12.3.4. Key Developments
12.4. Cryolife, Inc.
12.4.1. Overview
12.4.2. Financials
12.4.3. Products and Services
12.4.4. Key Developments
12.5. Organogenesis, Inc (Advanced Biohealing)
12.5.1. Overview
12.5.2. Financials
12.5.3. Products and Services
12.5.4. Key Developments
List of Tables
List of Figures

Baxter International
Stryker Corporation
Medtronic plc.
Cryolife, Inc.
Organogenesis, Inc (Advanced Biohealing)